−0.00EUR
16.88 M
About MALIN CORP PLC
Sector
Industry
Headquarters
Dublin
Website
Founded
2014
ISIN
IE00BVGC3741
FIGI
BBG012M9VNX9
Malin Corp. Plc. invests and supports innovative life sciences companies, which develops exceptional science and technology to deliver transformative outcomes for patients. Its priority assets includes Poseida, Immunocore, Kymab and Viamet. The company was founded on December 16, 2014 and is headquartered in Dublin, Ireland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on TURQUOISE exchange MALIN CORP PLC stocks are traded under the ticker MLCI.
Yes, you can track MALIN CORP PLC financials in yearly and quarterly reports right on TradingView.
MLCI net income for the last quarter is −1.10 M EUR, while the quarter before that showed 1.10 M EUR of net income which accounts for −200.00% change. Track more MALIN CORP PLC financial stats to get the full picture.
No, MLCI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MLCI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MALIN CORP PLC stock right from TradingView charts — choose your broker and connect to your account.
We've gathered analysts' opinions on MALIN CORP PLC future price: according to them, MLCI price has a max estimate of 15.50 EUR and a min estimate of 7.91 EUR. Read a more detailed MALIN CORP PLC forecast: see what analysts think of MALIN CORP PLC and suggest that you do with its stocks.